Skip to main content
. Author manuscript; available in PMC: 2010 Jun 18.
Published in final edited form as: Clin Cancer Res. 2009 May 26;15(11):3654–3662. doi: 10.1158/1078-0432.CCR-08-3293

Fig. 4.

Fig. 4

In multivariable Cox models (A and B), including cyclin B1 protein expression, tumor stage, grade and patient age, high primary tumor cyclin B1 protein expression assessed as a continuous variable by RPPA was a significant predictor of hormone receptor–positive breast tumor recurrence and patient death in 195 patients treated only with adjuvant tamoxifen after definitive locoregional therapy.